Paragon Private Wealth Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.1M Buy
3,050
+156
+5% +$53.4K 0.29% 92
2026
Q1
$1.02M Buy
2,894
+142
+5% +$50.6K 0.32% 88
2025
Q4
$901K Sell
2,752
-49
-2% -$15.5K 0.28% 102
2025
Q3
$790K Sell
2,801
-22
-0.8% -$6.38K 0.26% 114
2025
Q2
$788K Buy
2,823
+345
+14% +$97.7K 0.31% 94
2025
Q1
$772K Sell
2,478
-106
-4% -$31.3K 0.36% 79
2024
Q4
$673K Buy
2,584
+106
+4% +$31.4K 0.31% 91
2024
Q3
$798K Buy
2,478
+625
+34% +$204K 0.4% 72
2024
Q2
$579K Buy
1,853
+392
+27% +$115K 0.33% 87
2024
Q1
$415K Buy
1,461
+448
+44% +$131K 0.25% 100
2023
Q4
$292K Buy
+1,013
New +$276K 0.2% 110

Other funds holding AMGN

Paragon Private Wealth Management's AMGN Position: Q2 2026 in Review

Paragon Private Wealth Management increased its Amgen (AMGN) stake by 5.4% in Q2 2026, buying an estimated $53.4K and bringing the position to 3,050 shares worth $1.1M. The position accounts for 0.29% of the portfolio, ranked #92.

Paragon Private Wealth Management first reported a position in AMGN in Q4 2023 and has held it in 11 quarters since. 1,530 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Paragon Private Wealth Management held 3,050 shares of Amgen worth $1.1M as of Q2 2026.
  • Paragon Private Wealth Management bought 156 Amgen shares in Q2 2026, an estimated $53.4K.
  • Amgen made up 0.29% of Paragon Private Wealth Management's portfolio in Q2 2026, its #92 holding.
  • Paragon Private Wealth Management first reported a position in Amgen in Q4 2023 and has held it in 11 quarters since.
  • 1,530 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Paragon Private Wealth Management's 13F filing for Q2 2026, filed 28 Jul 2026.